Belpointe Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,341
Closed -$415K 764
2020
Q1
$415K Buy
2,341
+202
+9% +$38K 0.07% 275
2019
Q4
$408K Sell
2,139
-116
-5% -$20.9K 0.05% 361
2019
Q3
$379K Buy
2,255
+995
+79% +$162K 0.06% 346
2019
Q2
$211K Sell
1,260
-427
-25% -$59.1K 0.04% 401
2019
Q1
$247K Sell
1,687
-1,123
-40% -$163K 0.05% 272
2018
Q4
$376K Buy
2,810
+532
+23% +$87.2K 0.1% 231
2018
Q3
$434K Buy
2,278
+532
+30% +$97.7K 0.07% 291
2018
Q2
$291K Hold
1,746
0.08% 267
2018
Q1
$294K Sell
1,746
-341
-16% -$57.2K 0.09% 255
2017
Q4
$341K Buy
2,087
+135
+7% +$24.2K 0.07% 307
2017
Q3
$400K Buy
+1,952
New +$454K 0.09% 249

Other funds holding AGN

Belpointe Asset Management's AGN Position: Q2 2020 in Review

Belpointe Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,341 shares — an estimated $415K sold.

Belpointe Asset Management first reported a position in AGN in Q3 2017 and held it in 11 quarters. The position peaked at $434K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Belpointe Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Belpointe Asset Management sold 2,341 Allergan plc shares in Q2 2020, an estimated $415K.
  • Belpointe Asset Management first reported a position in Allergan plc in Q3 2017 and held it in 11 quarters.
  • Belpointe Asset Management's Allergan plc position peaked at $434K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Belpointe Asset Management's 13F filing for Q2 2020, filed 20 Jul 2020.